Latest1 information on COVID-19
©2022 Stanford Medicine
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Recruiting
I'm InterestedTrial ID: NCT01034033
Purpose
The purpose of this study is to try to understand the biology of development of breast,
ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk
for these diseases. The influence of environmental factors on cancer development in
individuals and families will be studied. The efficacy of treatments for these diseases will
be evaluated.
Official Title
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford Investigator(s)
James Ford
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Jafi Alyssa Lipson
Clinical Associate Professor, Radiology
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Daniel Rubin
Professor of Biomedical Data Science and of Radiology (Integrative Biomedical Imaging Informatics at Stanford), of Medicine (Biomedical Informatics Research) and, by courtesy, of Ophthalmology and of Computer Science
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
Eligibility
Inclusion Criteria:
I. Women who have a high risk of developing breast or ovarian cancer due to a known
germline mutation in the BRCA1/2, PTEN, CDH1, or TP53 cancer susceptibility genes, or due
to strong family history of either breast or ovarian cancer, in the absence of known cancer
susceptibility gene mutation.
II. Women who are approaching surgery for resection of a pelvic mass, which is considered
suspicious for neoplasia by radiologic or clinical criteria; such women may or may not also
meet criteria for inclusion in group I.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Meredith Mills
650-724-5223